The mortality of chronic kidney disease in Chinese subjects: a 12-year cohort based on clinical data in electronic health record
- PMID: 40765422
- PMCID: PMC12329842
- DOI: 10.1080/07853890.2025.2540021
The mortality of chronic kidney disease in Chinese subjects: a 12-year cohort based on clinical data in electronic health record
Abstract
Background: Chronic kidney disease (CKD) is a global health problem with increasing prevalence. The objective of this study was to investigate the CKD mortality rate in a large cohort study based on electronic health record (EHR).
Methods: This was a retrospective cohort based on Hospital's EHR. The follow-up period was from January 2008 to December 2019. We used demographics, laboratory tests, comorbidities and mortality information to do the analysis. The mortality data was gained from the Chinese Center for Disease Control and Prevention (CDC) database. Then the data was analyzed in the whole participants and subgroups.
Results: 82,684 CKD patients were identified in final cohort. Overall, there were 10,454 patients who died during the 12-year follow-up. The crude mortality rate was 12.6% (2.4 per 100 patient-years). In CKD stages 4-5, the mortality rate significantly increased (10.2 and 8.8 per 100 patient-years, respectively). The major causes of death including cardiovascular diseases, infections and cancer. In the advanced (stages 4-5) CKD, the proportion of deaths caused by cancer significantly decreased (15-26% to 9-10%), while the proportion of deaths caused by renal failure markedly increased (2-4% to 10-21%). In the death group, patients with younger baseline age have a higher proportion of reaching ESRD before death: among patients with baseline age ≤35 years, for example, the percentage who died with ESKD was 28.8%, and the percentage of died with ESKD in patients with baseline age >80 years was only 14.9%.
Conclusion: In conclusion, among the 82,684 CKD patients, the mortality rate was 2.4 per 100 patient-years. For advanced CKD patients, the mortality rate was significantly increased. As CKD progressed, deaths caused by cancer significantly decreased, while death caused by renal failure remarkably increased. Meanwhile, there may be a competing risk of all-cause mortality and progression to ESKD.
Keywords: Chronic kidney diseases; comorbidities; death causes; end-stage renal disease; mortality.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures
Similar articles
-
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210. Health Technol Assess. 2010. PMID: 20441712
-
Adherence to Plant-Based Diets and Risk of CKD Progression and All-Cause Mortality: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.Am J Kidney Dis. 2024 May;83(5):624-635. doi: 10.1053/j.ajkd.2023.09.020. Epub 2023 Dec 14. Am J Kidney Dis. 2024. PMID: 38103719 Free PMC article.
-
Antioxidants for chronic kidney disease.Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD008176. doi: 10.1002/14651858.CD008176.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2023 Nov 2;11:CD008176. doi: 10.1002/14651858.CD008176.pub3. PMID: 23076940 Free PMC article. Updated.
-
Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes.Cochrane Database Syst Rev. 2025 Feb 18;2(2):CD015849. doi: 10.1002/14651858.CD015849.pub2. Cochrane Database Syst Rev. 2025. PMID: 39963952
-
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).Cochrane Database Syst Rev. 2018 Aug 22;8(8):CD006023. doi: 10.1002/14651858.CD006023.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2025 Jun 27;6:CD006023. doi: 10.1002/14651858.CD006023.pub4. PMID: 30132304 Free PMC article. Updated.
References
-
- White SL, Polkinghorne KR, Atkins RC, et al. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. Am J Kidney Dis. 2010;55(4):660–670. doi: 10.1053/j.ajkd.2009.12.011. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials